Skip to main content

Table 1 Participant baseline characteristics

From: Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields

Patient no.

Group

Date of birth

Date of inclusion

Age at inclusion

Gender

Weight (kg)

KPS (%)

Tumor location

1

RGBM

07/1950

05/2004

53.8

Male

70

100

R. Temporoparietal

2

RGBM

08/1945

05/2004

58.8

Male

83

100

R. Temporal

3*

RGBM

06/1952

08/2004

52.2

Female

65

70

R. Parietal

4*

RGBM

08/1961

08/2004

43.1

Male

85

100

L. Frontoparietal

5

RGBM

05/1937

10/2004

67.5

Male

83

80

R. Temporoparietal

6

RGBM

05/1953

01/2005

51.7

Male

103

70

R. Parietooccipital

7

RGBM

04/1950

01/2005

54.8

Male

85

90

R. Frontotemporal

8

RGBM

06/1966

06/2005

39

Male

72

100

R. Temporoparietal

9

RGBM

06/1977

08/2005

28

Female

70

90

L. Temporoparietooccipital

10

RGBM

08/1948

09/2005

57

Female

68

70

L. Temporal

11

GBM

11/1968

01/2005

36

Male

77

100

L. Frontal

12

GBM

04/1935

05/2005

70

Male

79

90

R. Temporal

13*

GBM

12/1973

10/2005

32

Male

85

100

R. Frontal

14

GBM

03/1948

01/2006

58

Male

81

100

R. Temporal

15

GBM

10/1963

01/2006

42

Male

96

90

R. Temporal

16

GBM

03/1961

01/2006

45

Female

50

100

R. Frontal

17*

GBM

08/1973

04/2006

33

Female

65

90

R. Frontal

18

GBM

07/1951

10/2006

55

Male

80

100

L. Occipital

19

GBM

05/1941

09/2006

65

Male

85

80

L. Frontotemporal

20

GBM

05/1951

01/2007

56

Male

82

90

R. Temporal

  1. * case in present report.